{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T02:19:47Z","timestamp":1772072387074,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13643-018-0934-z","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T10:26:54Z","timestamp":1546943214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review"],"prefix":"10.1186","volume":"8","author":[{"given":"Maria Beatrice","family":"Passavanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniello","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Caterina","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Pota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Piccinno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manlio","family":"Barbarisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Aurilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7263-0229","authenticated-orcid":false,"given":"Marco","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"issue":"1","key":"934_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.expneurol.2010.03.022","volume":"224","author":"HS Hansen","year":"2010","unstructured":"Hansen HS. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Exp Neurol. 2010;224(1):48\u201355 \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2010.03.022\n                    \n                  .","journal-title":"Exp Neurol"},{"issue":"6","key":"934_CR2","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.biochi.2010.01.006","volume":"92","author":"S Petrosino","year":"2010","unstructured":"Petrosino S, Iuvone T, Di Marzo V. N-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities. Biochimie. 2010;92(6):724\u20137 \n                    https:\/\/doi.org\/10.1016\/j.biochi.2010.01.006\n                    \n                  .","journal-title":"Biochimie"},{"issue":"1","key":"934_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.vetimm.2009.06.011","volume":"133","author":"S Cerrato","year":"2010","unstructured":"Cerrato S, Brazis P, della Valle MF, Miolo A, Puigdemont A. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNF\u03b1 release from canine skin mast cells. Vet Immunol Immunopathol. 2010;133(1):9\u201315 \n                    https:\/\/doi.org\/10.1016\/j.vetimm.2009.06.011\n                    \n                  .","journal-title":"Vet Immunol Immunopathol"},{"key":"934_CR4","volume-title":"The endogenous ligand palmitoylethanolamide relieves neuropathic pain via mast cell and microglia modulation. 21st Annual Symposium Of The International Cannabinoid Research Society","author":"B Costa","year":"2011","unstructured":"Costa B, Colombo A, Bettoni I, Bresciani E, Torsello A, Comelli F. The endogenous ligand palmitoylethanolamide relieves neuropathic pain via mast cell and microglia modulation. 21st Annual Symposium Of The International Cannabinoid Research Society. St. Charles, Il. Usa: Pheasant Run; 2011. \n                    http:\/\/icrs.co\/SYMPOSIUM.2011\/ICRS2011.Final.Programme.pdf\n                    \n                  ."},{"issue":"1","key":"934_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/jpet.108.136903","volume":"326","author":"T Genovese","year":"2008","unstructured":"Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomelli D, Calignano A, Cuzzocrea S. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther. 2008;326(1):12\u201323. \n                    https:\/\/doi.org\/10.1124\/jpet.108.136903\n                    \n                  .","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"934_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.bbi.2011.02.006","volume":"25","author":"E Esposito","year":"2011","unstructured":"Esposito E, Paterniti I, Mazzon E, Genovese T, Di Paola R, Galuppo M, Cuzzocrea S. Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. Brain Behav Immun. 2011;25(6):1099\u2013112 \n                    https:\/\/doi.org\/10.1016\/j.bbi.2011.02.006\n                    \n                  .","journal-title":"Brain Behav Immun"},{"issue":"8","key":"934_CR7","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","volume":"92","author":"L Facci","year":"1995","unstructured":"Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A. 1995;92(8):3376\u201380 7724569.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"934_CR8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1074\/jbc.275.1.605","volume":"275","author":"T Sugiura","year":"2000","unstructured":"Sugiura T, Kondo S, Kishimoto S, Miyashita T, Nakane S, Kodaka T, Suhara Y, Takayama H, Waku K. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem. 2000;275(1):605\u201312 \n                    https:\/\/doi.org\/10.1074\/jbc.275.1.605January\n                    \n                   7, 2000.","journal-title":"J Biol Chem."},{"issue":"4","key":"934_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/sj.bjp.0704900","volume":"137","author":"B Costa","year":"2002","unstructured":"Costa B, Conti S, Giagnoni G, Colleoni M. Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems. Br J Pharmacol. 2002;137(4):413\u201320. \n                    https:\/\/doi.org\/10.1038\/sj.bjp.0704900\n                    \n                  .","journal-title":"Br J Pharmacol"},{"issue":"11","key":"934_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/bph.13580","volume":"174","author":"S Petrosino","year":"2017","unstructured":"Petrosino S, Di Marzo V. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol. 2017;174(11):1349\u201365. \n                    https:\/\/doi.org\/10.1111\/bph.13580\n                    \n                  .","journal-title":"Br J Pharmacol"},{"issue":"Pt 1","key":"934_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/bj3580249","volume":"358","author":"V Marzo Di","year":"2001","unstructured":"Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem J. 2001;358(Pt 1):249\u201355 11485574.","journal-title":"Biochem J"},{"issue":"1","key":"934_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12871-017-0461-9","volume":"17","author":"MB Passavanti","year":"2017","unstructured":"Passavanti MB, Fiore M, Sansone P, Aurilio C, Pota V, Barbarisi M, Fierro D, Pace MC. The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms. BMC Anesthesiol. 2017;17(1):171. \n                    https:\/\/doi.org\/10.1186\/s12871-017-0461-9\n                    \n                  .","journal-title":"BMC Anesthesiol"},{"issue":"12","key":"934_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s40266-017-0506-2","volume":"34","author":"F Germini","year":"2017","unstructured":"Germini F, Coerezza A, Andreinetti L, Nobili A, Rossi PD, Mari D, Guyatt G, Marcucci M. N-of-1 randomized trials of ultra-micronized palmitoylethanolamide in older patients with chronic pain. Drugs Aging. 2017;34(12):941\u201352 \n                    https:\/\/doi.org\/10.1007\/s40266-017-0506-2\n                    \n                  .","journal-title":"Drugs Aging"},{"issue":"1","key":"934_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pjnns.2017.11.002","volume":"52","author":"D Chirchiglia","year":"2018","unstructured":"Chirchiglia D, Chirchiglia P, Signorelli F. Nonsurgical lumbar radiculopathies treated with ultramicronized palmitoylethanolamide (umPEA): a series of 100 cases. Neurol Neurochir Pol. 2018;52(1):44\u20137. \n                    https:\/\/doi.org\/10.1016\/j.pjnns.2017.11.002\n                    \n                  .","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"934_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4081\/aiua.2017.1.17","volume":"89","author":"B Giammusso","year":"2017","unstructured":"Giammusso B, Di Mauro R, Bernardini R. The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis\/chronic pelvic pain syndrome: a randomized clinical trial. Arch Ital Urol Androl. 2017;89(1):17\u201321.","journal-title":"Arch Ital Urol Androl."},{"issue":"7","key":"934_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tun\u00e7alp \u00d6, Straus SE. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373 \n                    https:\/\/doi.org\/10.7326\/M18-0850\n                    \n                  .","journal-title":"Ann Intern Med"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0934-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-018-0934-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0934-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T19:25:36Z","timestamp":1578425136000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-018-0934-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1186\/s13643-018-0934-z","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"20 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests related to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"9"}}